NEW YORK – Bio-Techne said Thursday that its 2020 fiscal third quarter revenues rose 5 percent year over year, despite a negative impact on its growth from the coronavirus pandemic.
For the three months ended March 31, the Minneapolis, Minnesota-based firm said revenues rose to $194.7 million year over year from $184.9 million, beating analysts' average estimate of $185.4 million.